Tag: dyspnea

Latest News

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Newsemia
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with...
Gastroenterology

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Newsemia
Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line)...
Pharma / Biotech

PERJETA (Pertuzumab) Injection, Solution, Concentrate [Genentech, Inc.]

Newsemia
Updated Date: Oct 1, 2018 EST...
Pharma / Biotech

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE Tablet, Film Coated [Mylan Pharmaceuticals Inc.]

Newsemia
Updated Date: Sep 28, 2018 EST...
Gastroenterology

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Newsemia
Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the...
Latest News

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Newsemia
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy...
Latest News

Opdivo receives FDA approval as first Immuno-Oncology treatment option for small cell lung cancer

Newsemia
Bristol-Myers Squibb Company today announced that Opdivo received approval from the U.S. Food and Drug Administration as the first and only Immuno-Oncology treatment option for...
Pharma / Biotech

GEMCITABINE (Gemcitabine Hydrochloride) Injection, Powder, Lyophilized, For Solution [Sagent Pharmaceuticals]

Newsemia
Updated Date: Jul 27, 2018 EST...
Pharma / Biotech

IRBESARTAN AND HYDROCHLOROTHIAZIDE Tablet [Proficient Rx LP]

Newsemia
Updated Date: Jul 25, 2018 EST...
Pharma / Biotech

TIBSOVO (Ivosidenib) Tablet, Film Coated [Agios Pharmaceuticals, Inc.]

Newsemia
Updated Date: Jul 24, 2018 EST...
Pharma / Biotech

NAGLAZYME (Galsulfase) Solution [BioMarin Pharmaceutical Inc.]

Newsemia
Updated Date: Jul 24, 2018 EST...
Latest News

FDA approves first drug for treatment of adult AML patients with specific genetic mutation

Newsemia
The U.S. Food and Drug Administration today approved Tibsovo (ivosidenib) tablets for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML)...
Pharma / Biotech

PROGESTERONE Capsule [Preferred Pharmaceuticals Inc.]

Newsemia
Updated Date: Jul 20, 2018 EST...
Pharma / Biotech

NALBUPHINE HYDROCHLORIDE Injection, Solution [Hospira, Inc.]

Newsemia
Updated Date: Jul 18, 2018 EST...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy